NasdaqGM:SUPNPharmaceuticals
A Look At Supernus Pharmaceuticals (SUPN) Valuation After Strong 1 Year Returns And Pipeline Progress
Event Overview and Recent Share Performance
Recent trading in Supernus Pharmaceuticals (SUPN) has drawn attention, with the stock closing at US$51.61 and showing mixed short term performance, including a small gain over the past week and a decline over the past month.
See our latest analysis for Supernus Pharmaceuticals.
Beyond the latest move, the 1 year total shareholder return of 62.5% and 5 year total shareholder return of 61.94% suggest sustained interest in Supernus Pharmaceuticals,...